POWERED BY VIASKIN

What this means for you

Not registered yet, but its 24 Jul 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79458972

Mark type

Word mark

Filed

24 Jul 2026

Goods and services

• Class 035 — Advertising and business services: Advertising and marketing services; providing consumer product information regarding medical products to patients and healthcare professionals; advertising and marketing of medical goods, medical testing and diagnostic products and services; market research; business strategy and planning services; business data analysis; business management, organization and administration; retail services, online retail services and wholesale services connected with the sale of transdermal patches, skin patches and adhesive skin patches for medical use, transdermal and adhesive skin patches for treating, alleviating or preventing the development or progression of allergies or immunological disorders, transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals or medical preparations, patches or epicutaneous systems for the cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders, adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders, occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders, patches or epicutaneous systems containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders, patches or epicutaneous systems for use in the treatment of allergies or immunological disorders, patches or epicutaneous systems featuring allergens or antigens for treating allergies or immunological disorders, allergy medication, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating food allergies; retail services, online retail services and wholesale services connected with the sale of medical instruments, apparatus and devices for the cutaneous, epicutaneous or patch-based administration or delivery of medical or pharmaceutical substances for the treatment, alleviation or prevention of allergies or immunological disorders, pads and skin patches for receiving, holding or containing medical or pharmaceutical substances for the treatment, alleviation or prevention of allergies or immunological disorders, pads and skin patches for medical training purposes, pads and skin patches for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations, medical instruments, apparatus and devices sold without medication for the later administration, by cutaneous or epicutaneous means, of medical or pharmaceutical substances, pad, skin patch and occlusion patch dispensers and applicators for medical use; advisory, information and consultancy services relating to any or all of the aforesaid.
• Class 041 — Education and entertainment services: Educational and training services for consumers and medical professionals in the field of allergies and immunotherapy; provision of classes, seminars, programmes, conferences, congresses and workshops in the field of allergies and immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of allergies and immunotherapy; publication of periodicals, books, guides and databases in the field of allergies and immunotherapy; information, advisory and consultancy services relating to all of the aforesaid.
• Class 042 — Scientific and technological services: Medical and scientific research in the fields of allergies and immunotherapy; development of scientific methods for cutaneous and epicutaneous immunotherapy; medical and scientific research relating to the treatment, alleviation and prevention of autoimmune, infectious and inflammatory diseases; medical and scientific research in the fields of allergy treatment and care; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and the skin; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' skin; information, advisory and consultancy services relating to all of the aforesaid.
• Class 044 — Medical, beauty and agricultural services: Medical services relating to the treatment, alleviation and prevention of allergies; medical treatment, alleviation and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical or pharmaceutical substances, allergens or antigens using patches affixed to patients' skin; medical consultancy in the field of desensitization to allergies; providing medical information regarding medical conditions, allergies, intolerances, treatments and products to patients and healthcare professionals; provision of medical advice to patients and healthcare professionals regarding medical conditions, allergies, intolerances and treatment; providing medical information regarding medical products to patients and healthcare professionals; information, advisory and consultancy services relating to all of the aforesaid.

Owner

• DBV Technologies, FR

Prosecution history

• 27 Oct 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 26 Oct 2026 — NON-FINAL ACTION WRITTEN
• 23 Oct 2026 — ASSIGNED TO EXAMINER
• 29 Sept 2026 — APPLICATION FILING RECEIPT MAILED
• 29 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 24 Sept 2026 — NEW REPRESENTATIVE AT IB RECEIVED
• 24 Sept 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB